Annual accounts
Total Exemption Full accounts
31/12/2026Filing deadline
- Next accounts made up to
- 31/03/2026
- Last accounts made up to
- 31/03/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Termination of appointment of Rosemary Ann Scott as a director on 2026-03-16
Appointment of Ms Rosemary Ann Scott as a director on 2026-03-17
Cessation of Rosemary Scott Turner as a person with significant control on 2026-03-16
Notification of Rosemary Ann Scott as a person with significant control on 2026-03-17
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/12/2026Filing deadline
Confirms the registry record is up to date
The latest figures NEWMARKET BIOMEDICAL LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £1.90M
Total Assets
2024: £2.25M
Cash in Bank
2024: £1.06M
Total Liabilities
2024: £355.17K
Employees
2024: 13
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Cash in bank moved furthest, down 64.99% on 2024. See the full financial analysis for NEWMARKET BIOMEDICAL LIMITED.
The full financial record
Four ways through NEWMARKET BIOMEDICAL LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 15 | +2 |
| 2024 | 13 | +1 |
| 2023 | 12 | +2 |
| 2022 | 10 | 0 |
| 2021 | 10 | – |
Reported employee count increased from 10 in 2021 to 15 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 21/01/2011–Present | 1 | |
| Director | 17/03/2026–Present | 6 | |
| Director | 21/01/2011–31/07/2021 | 2 | |
| Director | 01/08/2021–Present | 3 | |
| Secretary | 21/01/2011–Present | 0 | |
| Director | 26/03/2014–Present | 0 | |
| Director | 08/07/2021–Present | 0 | |
| Director | 21/01/2011–16/03/2026 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–17/09/2024 | 1 | |
| 06/04/2016–Present | 1 | |
| 17/03/2026–Present | 6 | |
| 17/09/2024–16/03/2026 | 0 | |
| 17/09/2024–Present | 0 |
Every document on the Companies House record, newest first.
Termination of appointment of Rosemary Ann Scott as a director on 2026-03-16
Appointment of Ms Rosemary Ann Scott as a director on 2026-03-17
Cessation of Rosemary Scott Turner as a person with significant control on 2026-03-16
Notification of Rosemary Ann Scott as a person with significant control on 2026-03-17
Confirmation statement made on 2026-03-16 with no updates
Total exemption full accounts made up to 2025-03-31
Registered office address changed from 1 Lanwades Business Park Lanwades Business Park Newmarket Suffolk CB8 7PN England to Unit 1 Lanwades Business Park Kentford Suffolk CB8 7PN on 2025-11-07
Confirmation statement made on 2025-03-16 with updates
Total exemption full accounts made up to 2024-03-31
Notification of Rosemary Scott Turner as a person with significant control on 2024-09-17
Cessation of Colin Alexander Knox as a person with significant control on 2024-09-17
Confirmation statement made on 2024-03-21 with updates
Showing 12 of 17 filings
See when the next accounts and confirmation statement are due
45 UK companies are similar to NEWMARKET BIOMEDICAL LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
5th Floor Sustainable Ventures, County Hall, Westminster Bridge Road, London SE1 7PB
Unit 26-27, The Pantry Bakers Yard, Christon Road, Newcastle Upon Tyne NE3 1XD
Ketton Suite The King Centre, Main Road, Barleythorpe, Oakham LE15 7WD
2 Old Court Mews, 311a Chase Road, London N14 6JS
Sbarc, Spark 5th Floor, Maindy Rd, Cardiff CF24 4HQ
A short description of the company, written from its Companies House record.
NEWMARKET BIOMEDICAL LIMITED is a private limited company registered in the United Kingdom, based in Unit 1 Lanwades Business Park, Kentford, Suffolk CB8 7PN. Companies House classifies its business as Research and experimental development on biotechnology, one of 2 SIC classifications on its record. It has been on the register for 15 years 8 months.
The register currently records it as active. Its 2025 accounts report net assets of £1.27M and 15 employees.
Answered from this company's own registry record and filed figures.
Companies House records NEWMARKET BIOMEDICAL LIMITED under 2 registered business activities: Research and experimental development on biotechnology (72.11 - SIC 2007) and Other professional scientific and technical activities n.e.c. (74.90/9 - SIC 2007).
NEWMARKET BIOMEDICAL LIMITED is recorded as active on the Companies House register, and has been on it since 21/01/2011.
The most recent accounts Okredo holds cover 2025 and report net assets of £1.27M, total assets of £1.73M, cash in bank of £371.44K and total liabilities of £460.94K.
The most recent document on the record is dated 17/03/2026: Termination of appointment of Rosemary Ann Scott as a director on 2026-03-16, 6 months ago.
On the current registry record, accounts are due by 31/12/2026.
Companies House lists 8 officers (6 currently in post) and 5 people with significant control (3 current).